Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
73.3M
-
Shares change
-
+2.83M
-
Total reported value, excl. options
-
$1.15B
-
Value change
-
+$44.8M
-
Put/Call ratio
-
1.07
-
Number of buys
-
61
-
Number of sells
-
-52
-
Price
-
$15.67
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2014
162 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2014.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.3M shares
of 99.6M outstanding shares and own 73.59% of the company stock.
Largest 10 shareholders include FMR LLC (11.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.98M shares), ORBIMED ADVISORS LLC (5.79M shares), PERCEPTIVE ADVISORS LLC (4.57M shares), BB Biotech AG (3.12M shares), BlackRock Fund Advisors (2.56M shares), VANGUARD GROUP INC (2.28M shares), State Street Corp (2.22M shares), BlackRock Institutional Trust Company, N.A. (2.08M shares), and FRANKLIN RESOURCES INC (1.84M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.